Swedish Clinic Boosts Speed and Precision of Radiotherapy for Cancer Patients with Elekta Beam Shaping Technology

Fri Apr 12, 2013 1:48am EDT

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130412:nBw116686a

Uppsala University Hospital using two linear accelerators equipped with Elekta`s
Agility MLC 
UPPSALA, Sweden--(Business Wire)--
Regulatory News: 

Uppsala University Hospital is the first clinic in Scandinavia to treat cancer
patients using radiotherapy systems equipped with Elekta`s innovative Agility
160-leaf multileaf collimator (MLC). It will enable clinicians there to rapidly
and accurately tailor therapeutic radiation beams to tumor targets. The hospital
began treating patients with one Agility-equipped Elekta Synergy system last
October and in February 2013 became clinically operational with a second Elekta
Synergy with Agility. 

"The 5 mm leaves of Agility are particularly valuable in conforming to the shape
of small targets that are close to small at-risk organs," says Kristina Nilsson,
M.D., Co-Chief Radiation Oncologist at Uppsala University Hospital. "What`s
really useful is having that same leaf width across the entire 40 X 40 cm
treatment field, which means that we don`t have to limit highly conformal
treatments to targets in small fields - we can offer them to all patients." 

In addition to high precision, Agility provides market leading leaf speeds,
which has improved the clinic`s delivery times. For example, Agility combined
with Elekta`s continuously variable dose rate (CVDR) makes VMAT beam delivery
even faster, she adds. For a two arc VMAT plan, this combination has resulted in
reduction in delivery time from five minutes to just two minutes. 

"The transmission around the leaves also is lower in Agility than other MLCs,
which means with Agility we can reduce the lateral spread of the beam and
decrease the radiation dose to healthy organs and tissues," Dr. Nilsson notes. 

Uppsala University Hospital now treats 25 to 30 patients per day on each of the
Agility-equipped Synergy systems, for a total of 100 to 120 patients daily on
its two Elekta Synergy linear accelerators and two Precise Treatment System
machines. 

"With Agility, we`re providing patients in Uppsala and the country with faster
and more accurate treatments," Dr. Nilsson says. "In addition, with the low
transmission Agility provides, we`re also ensuring safer therapy by reducing
radiation exposure to organs-at-risk and normal tissues." 

For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time 

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time 

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on April 12, 2013. 

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives. 

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com. 

This information was brought to you by Cision http://news.cision.com

Elekta AB
Johan Andersson Melbi, +46 702 100 451
Director, Investor Relations,
johan.anderssonmelbi@elekta.com
or
Elekta
Michelle Joiner, +1 770-670-2447
Director, Global Public Relations and Brand Management
michelle.joiner@elekta.com


Copyright Business Wire 2013